शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
TTKHLTCAREBSETTK HEALTHCARE LIMITED· DiversifiedHighNeutral
Announced Thu, 6 Aug, 2026 · 13:19 IST

Q1 FY27 PAT up 64% YoY at Rs 21.3 cr; Rs 256 cr brand sale to Wipro

Profit growth above 25%Exceptional itemEBITDA margin expansionResults View source PDFExplain this filing

TTKHLTCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+3.8%Reaction day
₹1049.80
prior close
₹1083.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+3.5% vs market
Diversified peers, median of 12sector-0.9%+4.7% vs sector

On the reaction day the stock moved 3.5 pts more than Nifty Microcap 250 and 4.7 pts more than its Diversified peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+10.5
10m
+7.7
15m
+5.4
30m
+4.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+3.8+0.4+3.5-0.9+4.7
Next day
+2.4+0.4+2.0+0.1+2.3
2d
+1.7+0.3+1.4-0.2+1.9
3d
+2.8+0.2+2.7-0.8+3.7
4d
+4.3+0.5+3.7-0.6+4.9
5d
+9.0+0.7+8.3-2.1+11.1
1w
+9.1+0.9+8.2-2.3+11.5
15d
+2.9+1.6+1.3-1.9+4.8
1m
+3.5+2.4+1.2-1.7+5.2
2m
-1.9+1.1-3.0-7.1+5.2
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Diversified peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q1 FY27 revenue rose to Rs 257.6 cr from Rs 226.4 cr YoY. PAT jumped 64% to Rs 21.3 cr vs Rs 13 cr. EPS at Rs 15.06 vs Rs 9.24. Board approved sale of EVA and Good Home brands to Wipro Enterprises for Rs 256 cr plus GST, to close by Sept 30. USAID revived orders worth Rs 7 cr from previously written-off stock.

Likely market impact

Strong 64% PAT growth signals margin expansion. Rs 256 cr Wipro divestment will boost cash; core ops continue across consumer and medical devices.